Review Article

Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis

Table 4

Quality assessment of the included studies.

First author/yearSpectrum of patients (only information regarding seminoma patients were included)Consecutive or random selection of patientsReference standardApplication of reference standard regardless of index testEnough explanation of the index test to ensure reproducibility Independent blind comparison between index test and reference standard

Ganjoo, 1999 [14]Seminoma patients after primary or salvage chemotherapy N/AFollow-up including chest radiograph, tumor markers, physical examination, and CT YesYesN/A

Hain, 2000 [13]13 seminoma patients with possible relapseYesHistology or clinical follow-up (minimum of 18 months)YesYesN/A

Spermon, 2002 [12]10 seminoma patients after completion of first-line chemotherapyN/AHistology in 2 patients and clinical follow-up in 8 patients (serum tumour markers, CT, and the duration of the event-free follow-up) (median of 12 months) YesYesYes

De Santis, 2004 [11]Patients with metastatic pure seminoma who had radiographically defined postchemotherapy residual massesN/AHistology (11 resected masses) or follow-up (median of 34 months)YesYesN/A

Lewis, 2006 [10]Patients with residual mass after primary (14 patients) or salvage chemotherapy (10 patients)N/AHistology or clinical follow-upYesNoN/A

Hinz, 2008 [9]Patients with residual (18 patients) or recurrent (2 patients) after chemotherapyYesHistology YesYesYes (though CT information was available to the readers)

Bachner, 2012 [7]Patients with metastatic seminoma and residual masses after chemotherapyYesHistology or follow-up (at least 24 months)YesYesYes

Siekiera, 2012 [8]Patients with advanced seminoma after chemotherapy or radiotherapy in their follow-up schemeN/AHistology (7 patients) or follow-upYesNoN/A

Ambrosini, 2014 [6]Seminoma patients for restaging (16 patients), routine follow-up (18 patients), or suspected relapse (10 patients). Yes (all patients in a PET center)Histology or follow-upNo (the treatment of the patients was affected by the PET results)YesN/A